86.5%
melanomasolid tumorsnon-melanoma epithelial neoplasmsco-stimulatory molecule agonist antibodiesinterleukin-2
…stently observed across multiple institutions for patients with melanoma. This now-approved strategy approaches 35% in recent studies fr…